Benjamin Wirth

Benjamin Wirth

Auto-generated profile, based on publicly available information

Benjamin Wirth

Department of Endocrinology, HOCH Health Ostschweiz, St. Gallen, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Immunity
Verified
Journal Article
Closed access
JFJasna Friščić
Jasna Friščić
Martin BöttcherMartin Böttcher
Martin Böttcher
CRChristiane Reinwald
Christiane Reinwald
HBHeiko Bruns
Heiko Bruns
BWBenjamin Wirth
Benjamin Wirth
MHMarkus H Hoffmann
Markus H Hoffmann

12 March 2026 in medRxiv
Verified
Preprint
Open access
PDF file
VBVictoria Bruegger
Victoria Bruegger
MFMagdalena Fuchs
Magdalena Fuchs
QJQiuhan Jin
Qiuhan Jin
BWBenjamin Wirth
Benjamin Wirth
SBStefan Bilz
Stefan Bilz
MJMia Jovanova
Mia Jovanova
Introduction: Prediabetes, a key precursor to type 2 diabetes, is highly prevalent and underdiagnosed, particularly among adults aged ≥45 years with elevated body mass index (BMI). Early detection is critical because lifestyle interventions can delay or prevent progression to type 2 diabetes. The Glow Up (GLucose Observation and Wearable Use for Prevention) study aims to (1) test the feasibility of a digital biomarker for prediabetes screening using wearable– and smartphone-derived lifestyle factors (e.g., sleep, physical activity, and nutrition patterns), in daily life and to (2) characterize individual– and metabolic subgroup-level variability in lifestyle factors and glycemic control. Specifically, we aim to examine how lifestyle factors relate to diabetes risk and identify personalized predictors of early metabolic dysregulation. Methods and analysis: Glow Up is a prospective, single-center, observational case-control study conducted in Switzerland. Adults (N=200) aged ≥45 years with BMI ≥25 kg/m² will be recruited, including n=100 individuals with prediabetes and n=100 age– and sex-matched case-control normoglycemic controls. Participants will undergo four weeks of continuous monitoring using a blinded continuous glucose monitor (CGM), and commercial– and medical-grade wearables; e.g. capturing physical activity, sleep, and physiological markers (heart rate variability, heart rate and skin temperature); in addition to completing daily image-based meal logs, using smartphones. Glycated haemoglobin (HbA1c), fasting plasma glucose (FPG) and body anthropometrics will be collected at baseline and follow-up, four weeks apart. Primary outcomes include HbA1c and FPG, measured at approximately four week follow-up. Secondary outcomes include CGM metrics, lifestyle profiling (sleep, physical activity, stress, and nutrition), and adherence to image-based meal logging. Ethics and dissemination: The study has received ethics approval from the Ethics Committee of Eastern Switzerland (BASEC ID.: 2025-00972). Results will be published in international peer-reviewed journals and at national and international conferences as posters, presentations, and articles. Summaries will be provided to the funders and personalized reports to participants. Trial registration number: NCT07373418 Article Summary: Strengths and limitations of this study: Glow Up presents the first study in Switzerland to investigate glycaemic and lifestyle profiling among individuals with normoglycaemia and prediabetes in an observational, free-living setting. To our knowledge, Glow Up is the first dataset to combine continuous glucose monitoring, commercial– and medical-grade wearable sensors, smartphone-based questionnaires, image-based dietary logging under free-living conditions, and clinical biomarkers, HbA1c and FPG; allowing for rich digital phenotyping. Inclusion of baseline and follow-up clinical biomarkers (HbA1c and FPG) provides clinically validated ground truth measures, strengthening outcome validity and anchoring digital and wearable-derived markers to established clinical, diagnostic standards. The absence of direct measures of insulin resistance, lipid metabolism, and gut microbiome compositions may limit more mechanistic investigation of glucose dysregulation patterns and metabolic sub phenotyping. The four-week follow-up period may limit inference on longer-term glycaemic trajectories and progression to T2D. Findings may not be generalisable beyond at-risk adults living in Switzerland who meet the study eligibility criteria.

5 October 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
MFMagdalena Fuchs
Magdalena Fuchs
VBVictoria Brügger
Victoria Brügger
QJQiuhan Jin
Qiuhan Jin
BWBenjamin Wirth
Benjamin Wirth
SBStefan Bilz
Stefan Bilz
MJMia Jovanova
Mia Jovanova
Background: Accurate measurement of lifestyle factors is central to understanding how daily behaviors act as risk factors or protective buffers to noncommunicable diseases. While wearable devices enable passive monitoring of physical activity or sleep, nutritional intake still depends on active participant input, such as manual dietary logs or image-based recordings. Adherence to such logging tasks often declines rapidly, impacting data completeness and clinical utility. Theory-based reminders drawing on loss-framing or logging consistency feedback (ie, tracking streaks) can improve adherence to lifestyle data collection, but the effects of these strategies on repeated dietary logging remain unclear. Objective: The study aims to examine the effects of 2 theory-driven reminder strategies—loss-framing and logging consistency—on adherence to repeated, image-based meal logging. Methods: We conducted a microrandomized trial embedded within a 4-week observational lifestyle phenotyping study in Switzerland (N=200, age ≥45 y, BMI ≥25 kg/m²). Participants photographed their meals at each mealtime (breakfast, lunch, and dinner) using a mobile app over 28 days. A decision point was scheduled prior to participant-defined habitual mealtimes. Participants were randomly assigned with equal probability to (1) a reminder emphasizing loss of a daily financial reward for not logging (“loss-framing”), (2) a reminder providing feedback on recent logging consistency (“logging consistency”), or (3) a neutral reminder (“active control”). The proximal outcome is whether the participant logs a meal within 2 hours of receiving a reminder. Participants earned a daily financial reward contingent on meal-logging completion. To estimate intervention effects, we will use marginal excursion effect models for binary outcomes, adjusting time-varying covariates (eg, day in study) and baseline covariates (eg, age and gender). Ethics approval for this study was granted by the Cantonal Ethics Committee of Eastern Switzerland (BASEC ID 2025‐00972). Results: Enrollment began in November 2025, and the study was initiated on December 8, 2025. As of August 2026, 130 participants have been recruited, 120 have been enrolled, and 76 participants have completed the study, with an anticipated completion date of January 2027. Data analysis has not yet begun, and study results are expected to be published in Q2 2027. Conclusions: By clarifying the proximal effects of loss-framed and consistency-based reminders, findings will inform the design of future digital health studies to improve meal-logging adherence in daily life. This work contributes to the development of scalable, theory-driven reminder strategies for enhancing dietary data quality in observational and interventional research.

11 February 2026 in medRxiv
Verified
Preprint
Open access
PDF file
WMWasu Mekniran
Wasu Mekniran
VBVictoria Bruegger
Victoria Bruegger
MFMagdalena Fuchs
Magdalena Fuchs
QJQiuhan Jin
Qiuhan Jin
BWBenjamin Wirth
Benjamin Wirth
MJMia Jovanova
Mia Jovanova
Objectives: Digital biomarkers offer scalable screening for type 2 diabetes, yet adoption is stalled by uncertainty regarding economic viability. This study evaluates the cost-effectiveness and budget impact of digital screening compared to opportunistic screening from a Swiss payer perspective. Methods: A probabilistic Markov cohort model was developed to simulate at-risk Swiss adults (age ≥45, BMI ≥25 kg/m²) over a 40-year horizon. The model incorporates a digital attrition parameter, inputs derived from Swiss-specific sources (e.g., the CoLaus study and FSO life tables), and statutory tariffs. Costs and outcomes were discounted at 3.0%. Results: In the deterministic base-case, digital screening yielded an incremental cost-effectiveness ratio of CHF 2,912 per quality-adjusted life-year gained. Probabilistic sensitivity analysis indicated a 93.2% probability of cost-effectiveness at the CHF 50,000 threshold. The budget impact analysis estimated a Year 1 gross investment budget of CHF 27 million to identify prevalent cases, followed by long-term savings from averted complications. Conclusions: Digital screening can be highly cost-effective in Switzerland. While the required Year 1 gross investment poses a liquidity challenge, reimbursement via pathway-oriented models under the Swiss tariff could align incentives with long-term complication avoidance.

4 May 2026 in JMIR Preprints
Verified
Preprint
Open access
MFMagdalena Fuchs
Magdalena Fuchs
VBVictoria Brügger
Victoria Brügger
QJQiuhan Jin
Qiuhan Jin
BWBenjamin Wirth
Benjamin Wirth
SBStefan Bilz
Stefan Bilz
MJMia Jovanova
Mia Jovanova
BACKGROUND Accurate measurement of lifestyle factors is central to understanding how daily behaviors act as risk factors or protective buffers to non-communicable diseases. While wearable devices enable passive monitoring of physical activity or sleep, nutritional intake still depends on active participant input such as manual dietary logs or image-based recordings. Adherence to such logging tasks often declines rapidly, impacting data completeness and clinical utility. Theory-based reminders drawing on loss-framing or logging consistency feedback (i.e., tracking streaks) can improve adherence to lifestyle data collection, but effects of these strategies on repeated dietary logging remain unclear. OBJECTIVE To examine examines the effects of two theory-driven reminder strategies, loss-framing and logging consistency, on adherence to repeated, image-based meal-logging. METHODS We employ a micro-randomized trial (MRT) embedded within a 4-week observational lifestyle phenotyping study in Switzerland (N=200, age ≥45, BMI ≥25 kg/m²). Participants photograph their meals at each mealtime (breakfast, lunch, dinner) using a mobile app over 28 days. A decision point is scheduled prior to participant-defined habitual mealtimes. Participants are randomly assigned with equal probability to: (1) a reminder emphasizing loss of a daily financial reward for not logging ("loss-framing"), (2) a reminder providing feedback on recent logging consistency ("logging consistency"), or (3) a neutral reminder ("active control"). The proximal outcome is whether the participant logs a meal within two hours of receiving a reminder. Participants earn a daily financial reward contingent on meal logging completion. To estimate intervention effects, we will use marginal excursion effect models for binary outcomes, adjusting time-varying covariates (e.g., day in study) and baseline covariates (e.g., age, gender). Ethics approval for this study was granted by the Cantonal Ethics Committee of Eastern Switzerland (BASEC ID: 2025-00972). RESULTS Enrollment began in November 2025, and the study was initiated on December 8, 2025, with an anticipated completion date of January 2027. CONCLUSIONS By clarifying the proximal effects of loss-framed and consistency-based reminders, findings will inform the design of future digital health studies to improve meal-logging adherence in daily life. This work contributes to the development of scalable, theory-driven reminder strategies for enhancing dietary data quality in observational and interventional research. CLINICALTRIAL ClinicalTrials.gov NCT07555262; https://clinicaltrials.gov/study/NCT07555262 ClinicalTrials.gov NCT07373418; https://clinicaltrials.gov/ct2/show/NCT07373418

7 September 2026 in JMIR Preprints
Verified
Preprint
Open access
LALola Jo Ackermann
Lola Jo Ackermann
BWBenjamin Wirth
Benjamin Wirth
MBMichael Brändle
Michael Brändle
TKTobias Kowatsch
Tobias Kowatsch
BACKGROUND Diabetes mellitus type 2 (T2D) requires continuous self-management beyond clinical consultations, particularly in lifestyle-related domains such as nutrition and physical activity. However, maintaining these lifestyle behaviors in everyday life remains challenging for most patients. OBJECTIVE This study aimed to evaluate DALIA, a conversational agent-based lifestyle monitoring for capturing lifestyle-related data from patients with T2D and supporting brief daily reflection. Specifically, we explored patients’ everyday experiences of T2D self-management (RQ1), assessed DALIA’s feasibility, usability, and acceptability for multidomain lifestyle data capture (RQ2), and examined its perceived clinical relevance to routine T2D care (RQ3). METHODS We conducted a five-day mixed methods pilot feasibility study with 4 patients with T2D and 6 healthcare professionals (HCPs): 2 general practitioners, 2 endocrinologists, and 2 certified diabetes educators. DALIA combined structured chats, questionnaires, daily goal reflections, step counts, and meal-image analysis. Baseline patient interviews explored self-management experiences, while DALIA logs and follow-up interviews assessed data capture, feasibility, usability, and acceptability. HCP interviews examined potential clinical relevance. RESULTS T2D Participants had largely integrated medical self-management into their daily routines, whereas lifestyle behaviors, particularly nutrition and physical activity, remained harder to manage consistently. During the five-day intervention, DALIA captured multidomain lifestyle data, including daily check-ins, physical activity, nutrition, stress, wellbeing, sleep, medication routines, and diabetes-related check-up information. Completion of the five lifestyle and wellbeing questionnaires was 100% (20 of 20), daily check-in completion was 95% (19 of 20), step count data availability was 70.8% (17 of 24), and meal-image data capture was 75% (9 of 12). Participants perceived DALIA as easy to use and understand, with a median System Usability Scale score of 80.0 (range 67.5-97.5). Daily prompts, the one-topic-per-day structure, and goal setting supported reflection on everyday behaviors. Limitations concerned notification timing, sensor reliability, and meal-image capture. HCPs considered the collected lifestyle information potentially relevant to clinical care for making everyday self-management more visible, identifying recurring behavioral patterns and exceptions, and supporting more focused consultations. Although general practitioners, endocrinologists, and certified diabetes educators differed somewhat in emphasis, all three groups saw potential value in DALIA as a complementary tool for T2D care. CONCLUSIONS The findings support DALIA’s feasibility for short-term conversational lifestyle monitoring in patients with T2D and the potential usefulness of the resulting data for clinical discussions. Clinical use will require concise summaries, workflow integration, and technical robustness. Larger and longer-term studies should examine how DALIA-generated data can support patient-provider communication and sustained self-management.